DIA Conference To Provide New Paradigms In Evidence-Based Medicine And Health Technology Assessment The Drug Information Association (DIA) will host Evidence-based
Medicine and
Health Technology Assessment: Can We Find Common Ground? (September 22-23; Alexandria, VA).
Source: www.medicalnewstoday.comGender Differences In Experience Of Rheumatism Rheumatoid arthritis is often a more painful experience for women than it is for men, even though the visible symptoms are the same. Scientists are now saying that doctors should take more account of these subjective differences when assessing the need for medication. This and other findings are being presented at a congress currently in progress on gender
medicine arranged by Karolinska Institutet.
Source: www.medicalnewstoday.comNovacea Update On Asentar(TM) Novacea, Inc. (NASDAQ: NOVC), reported that it has received notice from the United States Food and Drug Administration (FDA) that the agency has released the clinical hold on the Asentar(TM) Investigational New Drug (IND) application. The FDA's response was based on the completion of their review of information submitted by Novacea to address issues relating to the clinical hold raised by the regulatory agency in November 2007.
Source: www.medicalnewstoday.com
# posted by Network @ 12:00 PM
